智通财经网·2025-06-20 12:11Group 1 - Nord Shares' revenue from copper foil business in solid-state battery applications accounts for less than 1% of total revenue, indicating limited contribution to overall performance and significant market competition [1] - Hainan Huatie clarifies that it does not engage in stablecoin business and has not reached any formal cooperation agreements with Ant Group regarding RWA [2] - Great Wall Military Industry reports normal production and operational activities despite a 37.06% stock price increase over four trading days [3] Group 2 - Huyou Pharmaceutical receives approval for clinical trials of injection HY0001a, a first-in-class innovative biological product for treating advanced solid tumors [4] - Changshan Pharmaceutical obtains approval for clinical trials of Aibennapeptide injection for weight loss indications, which acts as a GLP-1 receptor agonist [5] - Guangting Information signs an investment cooperation agreement to establish a digital automotive innovation laboratory, aimed at enhancing R&D capabilities in smart connected vehicles [6] Group 3 - Heng Rui Pharmaceutical receives six clinical trial approvals for various drug candidates, with total R&D investments ranging from approximately 1.43 billion to 11.7 billion yuan [7][8] - Lvtong Technology faces significant impact on its U.S. business due to a 119.33% anti-dumping duty on low-speed passenger vehicles, with U.S. revenue accounting for 29.14% of total revenue in 2024 [9] - *ST Jinguang receives a decision to terminate its stock listing, with the last trading date expected to be July 18, 2025 [10] Group 4 - Ningbo Huaxiang anticipates a net loss of 273 million to 369 million yuan for the first half of 2025, primarily due to the one-time impact of European business divestiture [11] - China State Construction reports a total of 18,412 billion yuan in new contracts signed from January to May, reflecting a year-on-year growth of 1.7% [12] - Guosheng Technology signs a 1.043 billion yuan sales contract for photovoltaic components, expected to positively impact future operating performance [13] - Zhejiang Jiaokao's subsidiary is expected to win a bid for a 1.897 billion yuan national highway reconstruction project [14]